155 related articles for article (PubMed ID: 7727511)
41. Antitumor activity of creatine analogs produced by alterations in pancreatic hormones and glucose metabolism.
Ara G; Gravelin LM; Kaddurah-Daouk R; Teicher BA
In Vivo; 1998; 12(2):223-31. PubMed ID: 9627806
[TBL] [Abstract][Full Text] [Related]
42. Subpopulations of mononuclear leukocytes associated with inhibition of Ehrlich ascites tumor growth by treatment with Bothrops jararaca venom.
de Vieira Santos MM; da Silva RJ; da Silva MG; Fecchio D
Mediators Inflamm; 2004 Feb; 13(1):29-32. PubMed ID: 15203562
[TBL] [Abstract][Full Text] [Related]
43. Effects of beta-guanidinopropionic acid on murine skeletal muscle.
Mahanna DA; Fitch CD; Fischer VW
Exp Neurol; 1980 Apr; 68(1):114-21. PubMed ID: 6444891
[No Abstract] [Full Text] [Related]
44. Curcumin's effects on sialic acid level and sialidase activity in Ehrlich ascites tumor bearing mice.
Ozen N; Uslu E; Ozen M; Aydin S; Altug T; Belce A; Kokoglu E
Tohoku J Exp Med; 2002 Aug; 197(4):221-7. PubMed ID: 12434997
[TBL] [Abstract][Full Text] [Related]
45. Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1alpha in Ehrlich ascites tumor cells.
Kumar A; D'Souza SS; Nagaraj SR; Gaonkar SL; Salimath BP; Rai KM
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1221-33. PubMed ID: 19370348
[TBL] [Abstract][Full Text] [Related]
46. Responses of beta-adrenoceptor in rat soleus to phosphorus compound levels and/or unloading.
Ohira Y; Saito K; Wakatsuki T; Yasui W; Suetsugu T; Nakamura K; Tanaka H; Asakura T
Am J Physiol; 1994 May; 266(5 Pt 1):C1257-62. PubMed ID: 8203490
[TBL] [Abstract][Full Text] [Related]
47. Brain ATP metabolism in hypoxia resistant mice fed guanidinopropionic acid.
Holtzman D; Brown M; O'Gorman E; Allred E; Wallimann T
Dev Neurosci; 1998; 20(4-5):469-77. PubMed ID: 9778586
[TBL] [Abstract][Full Text] [Related]
48. Growth-inhibition effects of oleic acid, linoleic acid, and their methyl esters on transplanted tumors in mice.
Zhu YP; Su ZW; Li CH
J Natl Cancer Inst; 1989 Sep; 81(17):1302-6. PubMed ID: 2769782
[TBL] [Abstract][Full Text] [Related]
49. The effects of silibin administration for different time periods on mouse liver with Ehrlich ascites carcinoma.
Beydogan AB; Bolkent S
Pharmacol Rep; 2016 Jun; 68(3):543-9. PubMed ID: 26891241
[TBL] [Abstract][Full Text] [Related]
50. [The interphase death of dividing cells. The effect of oxygen and the pH of the medium on the interphase death of Ehrlich ascites carcinoma cells under the action of ionizing radiation].
Korystov IuN; Dobrovinskaia OR; Degtiareva OV; Eĭdus LKh
Radiobiologiia; 1989; 29(4):457-62. PubMed ID: 2780978
[TBL] [Abstract][Full Text] [Related]
51. The effect of the creatine analogue beta-guanidinopropionic acid on energy metabolism: a systematic review.
Oudman I; Clark JF; Brewster LM
PLoS One; 2013; 8(1):e52879. PubMed ID: 23326362
[TBL] [Abstract][Full Text] [Related]
52. Cytoplasmic lipid in Ehrlich ascites tumor cells before and during recurrent growth.
Burns ER; Soloff BL
Oncology; 1971; 25(3):283-8. PubMed ID: 4949134
[No Abstract] [Full Text] [Related]
53. Effects of creatine and β-guanidinopropionic acid and alterations in creatine transporter and creatine kinases expression in acute seizure and chronic epilepsy models.
Kim DW; Yeo SI; Ryu HJ; Kim JE; Song HK; Kwon OS; Choi SY; Kang TC
BMC Neurosci; 2010 Oct; 11():141. PubMed ID: 20979657
[TBL] [Abstract][Full Text] [Related]
54. [The effect of ascitic fluid on the growth of Ehrlich tumor and Lewis carcinoma].
Donenko FV; Kabieva AO; Moroz LV
Biull Eksp Biol Med; 1992 Jul; 114(8):191-3. PubMed ID: 1467491
[TBL] [Abstract][Full Text] [Related]
55. Myocardial adaptation to creatine deficiency in rats fed with beta-guanidinopropionic acid, a creatine analogue.
Mekhfi H; Hoerter J; Lauer C; Wisnewsky C; Schwartz K; Ventura-Clapier R
Am J Physiol; 1990 Apr; 258(4 Pt 2):H1151-8. PubMed ID: 2184680
[TBL] [Abstract][Full Text] [Related]
56. Creatine transporter activity and content in the rat heart supplemented by and depleted of creatine.
Boehm E; Chan S; Monfared M; Wallimann T; Clarke K; Neubauer S
Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E399-406. PubMed ID: 12531746
[TBL] [Abstract][Full Text] [Related]
57. Muscle creatine uptake and creatine transporter expression in response to creatine supplementation and depletion.
Brault JJ; Abraham KA; Terjung RL
J Appl Physiol (1985); 2003 Jun; 94(6):2173-80. PubMed ID: 12611762
[TBL] [Abstract][Full Text] [Related]
58. Interaction of chronic creatine depletion and muscle unloading: effects on postural locomotor muscles.
Adams GR; Haddad F; Baldwin KM
J Appl Physiol (1985); 1994 Sep; 77(3):1198-205. PubMed ID: 7836122
[TBL] [Abstract][Full Text] [Related]
59. Influence of anethole treatment on the tumour induced by Ehrlich ascites carcinoma cells in paw of Swiss albino mice.
al-Harbi MM; Qureshi S; Raza M; Ahmed MM; Giangreco AB; Shah AH
Eur J Cancer Prev; 1995 Aug; 4(4):307-18. PubMed ID: 7549823
[TBL] [Abstract][Full Text] [Related]
60. Enhancement of doxorubicin-induced cytotoxicity by hyperthermia in Ehrlich ascites cells.
al-Shabanah OA; Osman AM; al-Harbi MM; al-Gharably NM; al-Bekairi AM
Chemotherapy; 1994; 40(3):188-94. PubMed ID: 8205937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
